| Patents for A61P 25 - Drugs for disorders of the nervous system (183,225) |
|---|
| 12/16/2009 | CN101601663A Multi-unit sustained-release preparation of levetiracetam and preparation method thereof |
| 12/16/2009 | CN101601655A Maleic acid cinepazide liposome injection and new application thereof |
| 12/16/2009 | CN101601468A Preparation method of wolfberry fruit and broomrape tonic wine |
| 12/16/2009 | CN100569797C Undecapeptide and application thereof |
| 12/16/2009 | CN100569796C Immune modulating peptide |
| 12/16/2009 | CN100569767C Phenylpyridylpiperazine compounds, a process for their preparation and pharmaceutical compositions containing them |
| 12/16/2009 | CN100569765C Citalopram intermediate crystal alkali |
| 12/16/2009 | CN100569281C Preparation and use of compositions for treating and preventing necrosis |
| 12/16/2009 | CN100569269C Painkiller |
| 12/16/2009 | CN100569266C Chinese medicine health care food |
| 12/16/2009 | CN100569248C Pharmaceutical composition for treating paralysis |
| 12/16/2009 | CN100569234C Ginkgo total lactone composition possessing nervo protection action |
| 12/16/2009 | CN100569223C Sumatriptan succinate rapid disintegrating tablet and preparation thereof |
| 12/15/2009 | US7632951 Inhibitors of integrin ανβ6 |
| 12/15/2009 | US7632872 Providing analgesia in a newborn subject, the method comprising administering to the subject or to the mother a therapeutically effective amount of xenon |
| 12/15/2009 | US7632870 Composition based on substituted 1,3-diphenylprop-2-en-1-one derivatives, preparation and uses thereof |
| 12/15/2009 | US7632865 N-(4-(3-chloro-5-trifluoromethyl-2-pyridyloxy)phenyl)-2-chloro-5-nitrothiobenzamide, for example; useful as preventive or therapeutic medicines for diseases accompanied by hyperactivated immune functions |
| 12/15/2009 | US7632858 For example, 1-(4-Cyano-2-ethyl-3-(trifluoromethyl)phenyl-1-carbamoyl)-3-hydroxy-pyrrolidine-2-carboxylic acid methyl ester; may be used in treatment of diseases or disorders associated with androgen receptor activity, such as maintenance of muscle strength and function in the elderly |
| 12/15/2009 | US7632850 2-amino-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate and 2-(methylamino)-2-oxoethyl 1-(4'-fluoro-1,1'-biphenyl-4-yl)cyclopropylmethylcarbamate; fatty acid amide (FAAH) hyrdrolase inhibitors; analgesics; neuropathic pain;psychological disorders; anticarcinogenic agents; AIDS |
| 12/15/2009 | US7632843 Administering LEK-8829 (9,10-didehydro-N-methyl-N-(2-propy-nyl)-6-methyl-8 beta-aminomethylergoline) as an antidote against acute (toxic) effects of cocaine overdosage to block euphorica effects, relieve the abstinence syndrome after withdrawal in addicts, and prevent craving for reinforcement |
| 12/15/2009 | US7632836 2-Morpholinoethyl ester of pivagabine; improved pharmacokinetic and therapeutic profiles; bioavailability; dosage; brain disorders; behavioral disorders; antidepressants; anxiolytic agents; neurodegenerative disorders; analgesics; eating disorders; antiarthritic agents; bipolar disorders; dysthymia |
| 12/15/2009 | US7632832 Antagonist for calcitonin gene related peptide (Cgrp); azepinone ligands; migranes; headaches; 1-[(2-methoxyethyl)-2-oxo-6-phenylazepan-3-yl]-4-(2-oxo-2,3-dihydro-1H-imidazo[4,5-b]pyridin-1-yl)piperidine-1-carboxamide |
| 12/15/2009 | US7632831 1H-indazoles, benzothiazoles, 1,2-benzoisoxazoles, 1,2-benzoisothiazoles, and chromones and preparation and uses thereof |
| 12/15/2009 | US7632826 Use of agonists of the glucocorticosteroid and/or mineralo-corticosteroid receptors, in particular corticosteroids for the treatment of addiction |
| 12/15/2009 | US7632825 Methods of decreasing or preventing pain using spicamycin derivatives |
| 12/15/2009 | US7632808 Use of MP52 or MP121 for the treatment and prevention of diseases of the nervous system |
| 12/15/2009 | US7632528 Simple and effective method for the prophylactic treatment of migraine substantially free of any side effects such as damage/irritation to the nasal mucosa membrane |
| 12/15/2009 | US7632524 Pharmaceutical preparations for the treatment of itch, nausea, hyperalgesia and the complications of opioid agonists |
| 12/15/2009 | US7632517 Buccal, polar and non-polar spray containing zolpidem |
| 12/15/2009 | CA2422698C Indoline derivatives and their use as 5-ht2 receptor ligands |
| 12/15/2009 | CA2393437C Exo-s-mecamylamine formulation and use in treatment |
| 12/15/2009 | CA2373180C Propanoic acid derivatives that inhibit the binding of integrins to their receptors |
| 12/15/2009 | CA2339008C Methods for increasing cytidine levels in vivo and treating cytidine-dependent human diseases |
| 12/15/2009 | CA2334189C Bridged indenopyrrolocarbazoles |
| 12/15/2009 | CA2267175C Alpha-9 integrin antagonists and anti-inflammatory compositions thereof |
| 12/15/2009 | CA2186763C Use of substituted dextranes for treating nervous system damage, and heparane sulphate-enriched fractions |
| 12/13/2009 | CA2668527A1 Novel azabicyclic derivatives, process for preparing them and pharmaceutical compounds containing them |
| 12/10/2009 | WO2009149435A2 Promoting axon regeneration in the adult cns through control of protein translation |
| 12/10/2009 | WO2009149135A1 Bis (hetero ) aryl substituted isoxazoles for use as neuronal nicotinic receptor modulators |
| 12/10/2009 | WO2009149003A1 Sofinicline (abt-894 ) for attention-deficit/hyperactivity disorder |
| 12/10/2009 | WO2009148659A2 Antimalarial quinolines and methods of use thereof |
| 12/10/2009 | WO2009148613A1 Treatment of pain with gap junction modulation compounds |
| 12/10/2009 | WO2009148564A1 Selenophene and selenazole carboxylic acid derivatives |
| 12/10/2009 | WO2009148403A1 Isoxazole derivatives and their use as metabotropic glutamate receptor potentiators |
| 12/10/2009 | WO2009148290A2 3-substituted propanamine compounds |
| 12/10/2009 | WO2009148287A2 Novel α-iso-cubebene compound extracted from schisandra chinensis and composition containing the compound as active ingredient for preventing and treating inflammatory diseases |
| 12/10/2009 | WO2009148148A1 Neuroinvasion inhibitor |
| 12/10/2009 | WO2009147831A1 Method and pharmaceutical composition for treatment of mental disorders |
| 12/10/2009 | WO2009147702A1 Cerebroprotective agent |
| 12/10/2009 | WO2009147681A1 Pharmaceutical compositions for treatment of parkinson's disease |
| 12/10/2009 | WO2009147665A1 Process for manufacture of a medicament with granulation and pan coating |
| 12/10/2009 | WO2009147442A1 Novel treatments |
| 12/10/2009 | WO2009147441A2 Novel treatments |
| 12/10/2009 | WO2009147434A1 A novel and efficient method for the synthesis of an amino acid |
| 12/10/2009 | WO2009147275A1 Use of statins as anticonvulsants, antiepileptics and neuroprotectors |
| 12/10/2009 | WO2009147234A2 Anxiolytic composition containing alphas1-casein-derived peptides |
| 12/10/2009 | WO2009147218A1 Pharmaceutical combination |
| 12/10/2009 | WO2009147187A1 4-carboxamide indazole derivatives useful as inhibitors of p13-kinases |
| 12/10/2009 | WO2009147167A1 Indane derivatives as ampa receptor modulators |
| 12/10/2009 | WO2009146875A1 Pharmaceutical compositions comprising gamma secretase modulators |
| 12/10/2009 | WO2009146523A1 Compositions comprising liposomes, an antigen, a polynucleotide and a carrier comprising a continuous phase of a hydrophobic substance |
| 12/10/2009 | WO2009129476A3 An antibody bound synthetic vesicle containing active agent molecules |
| 12/10/2009 | WO2009128057A3 Growth factor modulators for the treatment of anxiety, depression and cognitive disorders |
| 12/10/2009 | WO2009128050A3 An histone deacetylase inhibitor in combination with a sirtuin activator agent for the treatment of neurodegenerativediseases and tumors or neoplasms |
| 12/10/2009 | WO2009127642A3 Use of lrrk2 inhibitors for neurodegenerative diseases |
| 12/10/2009 | WO2009120484A3 Pharmaceutical gels and methods for delivering therapeutic agents to a site beneath the skin |
| 12/10/2009 | WO2009119982A3 Adamantine derivative for inhibiting toxicity of amyloid oligomer |
| 12/10/2009 | WO2009117418A3 Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration |
| 12/10/2009 | WO2009114539A3 Neuroprotective integrin-binding peptide and angiopoietin-1 treatments |
| 12/10/2009 | WO2009112674A3 Compounds for use in the treatment of neuropathic pain |
| 12/10/2009 | WO2009112541A3 Combination therapy with pm00104 and another antitumor agent |
| 12/10/2009 | WO2009110984A3 Contrast agents for applications including perfusion imaging |
| 12/10/2009 | WO2009109618A3 1-benzyl-3-hydroxymethylindazole derivatives and use thereof in the treatment of diseases based on the expression of mcp-1, cx3cr1 |
| 12/10/2009 | WO2009109613A3 1-BENZYL-3-HYDROXYMETHYLINDAZOIιE DERIVATIVES AND USE THEREOF IN THE TREATMENT OF DISEASES BASED ON THE EXPRESSION OF MCP-1, CX3CR1 |
| 12/10/2009 | WO2009108804A3 Steroid analogues for neuroprotection |
| 12/10/2009 | WO2009105162A3 Hsp90 inhibitors or modulators for treatment or prevention of substance-related disorders |
| 12/10/2009 | WO2009104184A3 Extracts of sclerocarya birrea |
| 12/10/2009 | WO2009103105A3 Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders |
| 12/10/2009 | WO2009098008A3 3-(2-dimethylaminomethyl-cyclohexyl)-phenol against polyneuropathic pain |
| 12/10/2009 | WO2009074990A3 Rtp801l sirna compounds and methods of use thereof |
| 12/10/2009 | WO2009060318A3 Polymorphic forms of ramelteon and processes for preparation thereof |
| 12/10/2009 | WO2009055644A3 Agonists and antagonists of guanylate cyclase receptors of the grueneberg ganglion for use in modulating animal behaviour |
| 12/10/2009 | WO2009054994A3 Use of compounds activating sirt-3 for mimicking exercise |
| 12/10/2009 | WO2008148801A8 Disubstituted phenylpyrrolidines as modulators of cortical catecholaminergic neurotransmission |
| 12/10/2009 | WO2008135830A8 N- [6-amino-5- (phenyl) pyrazin-2-yl] -isoxazole-4-carboxamide derivatives and related compounds as nav1.8 channel modulators for the treatment of pain |
| 12/10/2009 | US20090306408 2-Amino-Bicyclo (3.1.0) Hexane-2,6-Dicarboxylic Ester Derivative |
| 12/10/2009 | US20090306221 Use for Cannabinoid |
| 12/10/2009 | US20090306204 Pharmaceutical Composition Comprising Cyclobenzaprine and Aceclofenac in Association |
| 12/10/2009 | US20090306200 Prophylactic or Therapeutic Agent for Nocturnal Conduct Disorder Associated With Dementia |
| 12/10/2009 | US20090306168 SirT Inhibitors That Bind to NAD |
| 12/10/2009 | US20090306167 Pharmaceutical Compositions for Intranasal Administration Comprising a Melatonin Receptor Agonist, Uses Thereof |
| 12/10/2009 | US20090306160 Methods for improving drug disposition |
| 12/10/2009 | US20090306158 Metabotropic Glutamate Receptor Isoxazole Ligands and Their Use as Potentiators 286 |
| 12/10/2009 | US20090306155 Thiazoles, imidazoles, and pyrazoles useful as inhibitors of protein kinases |
| 12/10/2009 | US20090306144 Pyridine derivatives of alkyl oxindoles as 5-ht7 receptor active agents |
| 12/10/2009 | US20090306141 Novel Compounds |
| 12/10/2009 | US20090306137 Treatment for depressive disorders |
| 12/10/2009 | US20090306136 Benzenesulfonamide Compounds and the Use Thereof |
| 12/10/2009 | US20090306129 Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
| 12/10/2009 | US20090306121 Aza-beta-carbolines and methods of using same |